Cyto-Facto
About:
Cyto-Facto is a biotechnology company that develops and manufactures CAR-T cell therapies and mesenchymal stem cell products.
Website: https://www.cytofacto.com/
Top Investors: SMBC Venture Capital, Mitsubishi Corporation, Mizuho Capital, Asahi Kasei, MPower Partners
Description:
Cyto-Facto is a biotechnology company that develops and manufactures CAR-T cell therapies and mesenchymal stem cell products.
Total Funding Amount:
1.18B JPY
Headquarters Location:
Chuo, Hokkaido, Japan
Founded Date:
2022-10-18
Founders:
Number of Employees:
51-100
Last Funding Date:
2024-04-22
IPO Status:
Private
Industries:
© 2025 bioDAO.ai